Definitive Contract HHSN261201200072C
Award Date
9/28/12
Potential Completion Date
7/29/13
Potential Value
$200K
Federal Agency
National Cancer Institute
Awardee
Nanocellect Biomedical Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
45
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $198,641 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI) to Nanocellect Biomedical Inc., a for-profit biotechnology company. The contract is for the development of a "CTC Label and Capture by Lab-on-a-Chip Flow-Cytometry" solution, which aligns with the NCI's research interests. Nanocellect Biomedical is an innovative provider of automated cell analysis, sorting, and dispensing equipment and services, with a strong...
The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm-fixed-price purchase order contract to Nanocellect Biomedical Inc., a for-profit organization, for a microfluidic cell sorter. The total potential value of the contract is $149,680.00, with a completion date of August 31, 2022. The contract does not have a set-aside designation. Nanocellect Biomedical is a biotechnology company that provides automated cell analysis, sorting, and dispensing equipment,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...
This is a $100,000.00 firm fixed price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Nanocellect Biomedical Inc., a small business, for a small sized cell sorter with single cell dispenser. The award was made on August 6, 2018 with an ultimate completion date of August 5, 2019. Nanocellect Biomedical has provided cell sorting systems and related services to various federal agencies, and this contract supports the company's...
This Small Business Innovation Research (SBIR) Phase I contract, valued at $399,674, was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Inso Biosciences Inc., a small biotechnology startup. The contract supports the research and development of advanced sample processing platforms for downstream single-cell multi-omic analysis. This work aligns with the NIH and Centers for Disease Control and Prevention (CDC) mission to develop medical...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, a civilian agency, to Nanohmics Inc., a small for-profit technology company based in Austin, Texas. The contract, valued at $299,999.00, is for the development of a compact cell-free DNA detection array under SBIR Topic 353. As a total small business set-aside contract, this award supports Nanohmics' capabilities in advanced electronics, optics, sensors, and imaging systems,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Mental Health (NIMH), a civilian agency within the National Institutes of Health (NIH), to Nanocellect Biomedical Inc., a for-profit biotechnology company. The $85,000.00 contract is for the delivery of Nanocellect's WOLF and WOLF G2 cell sorting systems and N1 single-cell dispensers, along with associated maintenance services. These advanced microfluidic cell analysis tools are designed to support a wide...
This is a $1,000,000.00 Phase II SBIR contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for the rapid screening of individual cells using single cell mass spectrometry, supporting the NCI's biomedical research and development efforts. Nanocomposix has previously supported other federal agencies such as the Department of Defense...
Nanocellect Biomedical Inc., a for-profit biotechnology company, was awarded a $115,390.00 firm fixed price purchase order from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute. The award was for the provision of a NanoCellect WOLF Cell Sorter and N1 Cell Dispenser, which aligns with the original solicitation for these products. No set-aside designation was used. Nanocellect Biomedical has a history of providing...
This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...